These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36506545)

  • 1. Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study.
    Shi P; Ruan Y; Zhong C; Teng L; Ke L; Yao H
    Front Pharmacol; 2022; 13():1062026. PubMed ID: 36506545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Pharmacokinetic Markers for Guanxin Danshen Drop Pills in Rats by Combination of Pharmacokinetics, Systems Pharmacology, and Pharmacodynamic Assays.
    Yao H; Huang X; Xie Y; Huang X; Ruan Y; Lin X; Huang L; Shi P
    Front Pharmacol; 2018; 9():1493. PubMed ID: 30622470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
    Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Integrated Pharmacokinetic Study of an
    Shi P; Xie Y; Xie R; Lin Z; Yao H; Wu S
    Front Pharmacol; 2020; 11():1295. PubMed ID: 32922299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study.
    Chen Q; Wan J; Zhang Y; He Y; Bao Y; Yu L; Yang J
    Biomed Pharmacother; 2022 Jun; 150():112950. PubMed ID: 35427818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of multiple chemical and biological approaches for quality assessment of Carthamus tinctorius L. (safflower) by determining both the primary and secondary metabolites.
    Jia-Xi L; Chun-Xia Z; Ying H; Meng-Han Z; Ya-Nan W; Yue-Xin Q; Jing Y; Wen-Zhi Y; Miao-Miao J; De-An G
    Phytomedicine; 2019 May; 58():152826. PubMed ID: 30836217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers.
    Li CY; Yin JG; Zhang J; Wang XX; Xu MJ; Liu F; Zou JD; Ju WZ
    J Ethnopharmacol; 2015 Mar; 162():225-30. PubMed ID: 25576896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Active Ingredients of Salvia miltiorrhiza and Carthamus tinctorius in Compatibility in Normal and Cerebral Ischemia Rats: A Comparative Study.
    Jin Y; Yu L; Xu F; Zhou J; Xiong B; Tang Y; Li X; Liu L; Jin W
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):273-284. PubMed ID: 31828667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective ion monitoring of quinochalcone C-glycoside markers for the simultaneous identification of Carthamus tinctorius L. in eleven Chinese patent medicines by UHPLC/QTOF MS.
    Si W; Yang W; Guo D; Wu J; Zhang J; Qiu S; Yao C; Cui Y; Wu W
    J Pharm Biomed Anal; 2016 Jan; 117():510-21. PubMed ID: 26476296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS combined with blood-brain dual channel microdialysis for simultaneous determination of active components of astragali radix-safflower combination and neurotransmitters in rats with cerebral ischemia reperfusion injury: Application in pharmacokinetic and pharmacodynamic study.
    Du Y; Li C; Xu S; Yang J; Wan H; He Y
    Phytomedicine; 2022 Nov; 106():154432. PubMed ID: 36113188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.
    Ao H; Feng W; Peng C
    Evid Based Complement Alternat Med; 2018; 2018():8259280. PubMed ID: 30356354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greener extraction process and enhanced in vivo bioavailability of bioactive components from Carthamus tinctorius L. by natural deep eutectic solvents.
    Tong X; Yang J; Zhao Y; Wan H; He Y; Zhang L; Wan H; Li C
    Food Chem; 2021 Jun; 348():129090. PubMed ID: 33524695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Activities of Safflower Yellow and Its Clinical Applications.
    Chen Y; Li M; Wen J; Pan X; Deng Z; Chen J; Chen G; Yu L; Tang Y; Li G; Xie X; Peng C
    Evid Based Complement Alternat Med; 2022; 2022():2108557. PubMed ID: 35795285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vascular dilatation induced by Hydroxysafflor yellow A (HSYA) on rat mesenteric artery through TRPV4-dependent calcium influx in endothelial cells.
    Yang J; Wang R; Cheng X; Qu H; Qi J; Li D; Xing Y; Bai Y; Zheng X
    J Ethnopharmacol; 2020 Jun; 256():112790. PubMed ID: 32234595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Optimization of the Ultrasonic Extraction Method and Determination of the Antioxidant Activities of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B from Safflower Using a Response Surface Methodology.
    Zhang Y; Yu L; Jin W; Li C; Wang Y; Wan H; Yang J
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32182800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects.
    Zhao F; Wang P; Jiao Y; Zhang X; Chen D; Xu H
    Front Pharmacol; 2020; 11():579332. PubMed ID: 33536906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating molecular characterization and metabolites profile revealed CtCHI1's significant role in Carthamus tinctorius L.
    Guo D; Gao Y; Liu F; He B; Jia X; Meng F; Zhang H; Guo M
    BMC Plant Biol; 2019 Aug; 19(1):376. PubMed ID: 31455221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research.
    Zhang X; Shen D; Feng Y; Li Y; Liao H
    J Immunol Res; 2021; 2021():4560012. PubMed ID: 34938814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia.
    Zhou J; Li M; Jin W; Li X; Fan H; Zhang Y
    Pharmacology; 2018; 102(3-4):154-160. PubMed ID: 30045035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.